How Has the Proton Therapy Systems Market Size Evolved in Recent Years?
The proton therapy systems market has seen considerable growth due to a variety of factors.
• The market size of proton therapy systems has experienced swift growth in the last few years. It is projected to rise from $1.29 billion in 2024 to $1.44 billion in 2025, showcasing a compound annual growth rate (CAGR) of 10.9%.
This substantial growth witnessed in the historic period can be credited to factors such as the surge in cancer cases, heightened awareness among medical professionals, the expansion of healthcare facilities, an upsurge in healthcare expenses, and a demand for non-surgical treatment choices.
What Is The Forecast For The Proton Therapy Systems Market Size?
The proton therapy systems market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, we are likely to see an escalated growth in the proton therapy systems market, with projections showing it reaching $2.15 billion in 2029, having a compound annual growth rate (CAGR) of 10.6%.
This growth in the predictive period can be linked to the rise in cancer cases, the increasing use of proton therapy, the growth in its acceptance in pediatric oncology, a rising tendency towards outpatient cancer treatment environments, and an increasing focus on environmental sustainability. Significant trends for this forecast period are the adoption of proton therapy, technological progress, the implementation of artificial intelligence, the embracing of pencil beam scanning technology, and the use of hypo fractionated proton therapy.
What Are The Essential Drivers Behind The Growth Of The Proton Therapy Systems Market?
With the rise in cancer incidence, the proton therapy systems market is anticipated to expand. Cancer, characterized by abnormal cell growth that can permeate and spread across the body, is becoming increasingly common. Contributing factors towards this rise include an aging population, lifestyle modifications, environmental triggers, and enhanced detection and diagnostic practices. Proton therapy systems are favored in cancer treatment for their precision in focusing on tumors with high radiation doses while limiting harm to the surrounding healthy tissues. This approach could potentially lessen side effects and enhance treatment results. For example, the American Cancer Society, a non-profit cancer advocacy organization based in the US, reported that the number of cancer cases escalated to 1,958,310 in 2023, marking a 3.16% increase from 1,898,160 in 2021. Thus, the escalating occurrence of cancer is driving the evolution of the proton therapy systems market.
How Is The Global Proton Therapy Systems Market Divided Into Key Segments?
The proton therapy systems market covered in this report is segmented –
1) By Type: Proton Therapy Systems With Robotized Positioning Table, Proton Therapy Systems With Integrated CT Scanner, Proton Therapy Systems With Integrated PET Scanner
2) By Setup Type: Single Room, Multi Room
3) By Application: Brain And Central Nervous System Cancer, Head And Neck Cancer, Prostate Cancer, Breast Cancer, Lung Cancer, Gastrointestinal Cancer, Other Applications
4) By End-User: Hospitals, Proton Therapy Center, Other End-Users
Subsegments:
1) By Proton Therapy Systems With Robotized Positioning Table: Fixed Position Robotized Table Systems, Movable Position Robotized Table Systems
2) By Proton Therapy Systems With Integrated CT Scanner: Conventional CT Scanner Integrated Systems, High-Resolution CT Scanner Integrated Systems
3) By Proton Therapy Systems With Integrated PET Scanner: Low-Dose PET Scanner Integrated Systems, High-Resolution PET Scanner Integrated Systems
Pre-Book The Proton Therapy Systems Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Proton Therapy Systems Industry?
Key players in the proton therapy systems market are shifting their focus towards manufacturing more compact and easy-to-access systems including self-shielded proton accelerators to tackle issues related to space constraints and the complexity of installing. By significantly decreasing the need for additional external shielding structures that conventional proton therapy systems require, a self-shielded proton accelerator increases safety and makes installation processes straightforward. For example, in October 2022, an innovative medical equipment corporation from the US, Mevion Medical Systems, launched their brand new product, the MEVION S250-FIT proton therapy system. This system incorporates Mevion's cutting-edge self-shielded proton accelerator and is the only comprehensive proton treatment solution in the industry that can be utilized with existing LINAC vaults. It is capable of rapidly integrating emerging technologies like ARC therapy. The FIT system is expected to significantly lower the hurdles for adopting proton treatment.
Who Are the Key Players In The Proton Therapy Systems Market?
Major companies operating in the proton therapy systems market report are:
• Mitsubishi Electric Corporation
• Toshiba Corporation
• Siemens Healthineers
• Koninklijke Philips N.V.
• GE Healthcare
• Sumitomo Heavy Industries Ltd.
• Hitachi High-Tech Corporation
• Acibadem Healthcare Group
• Elekta AB
• Mirion Technologies
• Ion Beam Applications SA
• Sirtex Medical Limited
• RaySearch Laboratories
• Mevion Medical Systems
• Sun Nuclear Corporation
• ITEL Telecomunicazioni S.r.l
• Advanced Oncotherapy plc
• Provision Healthcare
• Optivus Proton Therapy Inc.
• Provision Proton Partners International
• Danfysik A/S
• ProTom International
• Best Cyclotron Systems
• ACCEL Instruments GmbH
• P-Cure Ltd.
What Are The Regional Insights Into The Proton Therapy Systems Market?
North America was the largest region in the proton therapy systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proton therapy systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
